CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: prostaglandin F2alpha
Accession: CHEBI:15553
browse the term
Definition: A prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is a naturally occurring prostaglandin used to induce labor.
Synonyms: exact_synonym: (5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid
related_synonym: (5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate; 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid; 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid; 9a,11a-PGF2; Amoglandin; Cyclosin; Dinoprost; Enzaprost; Enzaprost F; Formula=C20H34O5; InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1; InChIKey=PXGPLTODNUVGFL-YNNPMVKQSA-N; PGF2a; PGF2alpha; Panacelan; Prostaglandin F2a; Prostin F 2 alpha; Protamodin; SMILES=CCCCC[C@H](O)\\C=C\\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\\C=C/CCCC(O)=O; U 14583; dinoprosta; dinoprostum; l-PGF2-alpha; l-Prostaglandin F2-alpha
alt_id: CHEBI:10913; CHEBI:26327; CHEBI:8516
xref: CAS:551-11-1; Drug_Central:912; HMDB:HMDB0001139; KEGG:C00639; KEGG:D00081; LIPID_MAPS_instance:LMFA03010002
xref_mesh: MESH:D015237
xref: MetaCyc:5Z13E-15S-9-ALPHA11-ALPHA15-TRIHY; PMID:11438482; PMID:23807981; Reaxys:2225571; VSDB:1803; Wikipedia:Dinoprost
cyclic_relationship: is_conjugate_acid_of CHEBI:57404
G
CASP3
caspase 3
increases activity increases expression multiple interactions
EXP
Dinoprost results in increased activity of CASP3 protein Dinoprost results in increased expression of CASP3 mRNA [epostane co-treated with Dinoprost] results in increased activity of CASP3 protein; Dinoprost promotes the reaction [epostane results in increased expression of CASP3 mRNA]; epostane promotes the reaction [Dinoprost results in increased expression of CASP3 mRNA]
CTD
PMID:20739670
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CCL2
chemokine (C-C motif) ligand 2
increases expression multiple interactions
EXP
Dinoprost results in increased expression of CCL2 mRNA [Dinoprost co-treated with epostane] results in increased expression of CCL2 mRNA
CTD
PMID:21505051
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCL4
C-C motif chemokine ligand 4
increases expression multiple interactions
EXP
Dinoprost results in increased expression of CCL4 mRNA [Dinoprost co-treated with epostane] results in increased expression of CCL4 mRNA
CTD
PMID:21505051
NCBI chr12:39,479,190...39,480,511
Ensembl chr12:39,478,882...39,481,082
G
CCL8
chemokine (C-C motif) ligand 8
increases expression multiple interactions
EXP
Dinoprost results in increased expression of CCL8 mRNA [Dinoprost co-treated with epostane] results in increased expression of CCL8 mRNA
CTD
PMID:21505051
NCBI chr12:40,740,468...40,741,970
Ensembl chr12:40,740,023...40,742,022
G
CCR1
C-C motif chemokine receptor 1
multiple interactions increases expression
EXP
epostane promotes the reaction [Dinoprost results in increased expression of CCR1 mRNA]
CTD
PMID:21505051
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
G
CCR2
C-C motif chemokine receptor 2
increases expression multiple interactions
EXP
Dinoprost results in increased expression of CCR2 mRNA epostane promotes the reaction [Dinoprost results in increased expression of CCR2 mRNA]
CTD
PMID:21505051
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
G
CCR5
C-C motif chemokine receptor 5
increases expression multiple interactions
EXP
Dinoprost results in increased expression of CCR5 mRNA epostane promotes the reaction [Dinoprost results in increased expression of CCR5 mRNA]
CTD
PMID:21505051
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CXCL2
chemokine (C-X-C motif) ligand 2
multiple interactions increases expression
EXP
[Dinoprost co-treated with epostane] results in increased expression of CXCL2 mRNA Dinoprost results in increased expression of CXCL2 mRNA
CTD
PMID:21505051
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression multiple interactions
EXP
Dinoprost results in increased expression of CXCL8 mRNA [Dinoprost co-treated with epostane] results in increased expression of CXCL8 mRNA
CTD
PMID:21505051
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCR2
C-X-C motif chemokine receptor 2
multiple interactions increases expression
EXP
epostane promotes the reaction [Dinoprost results in increased expression of CXCR2 mRNA]
CTD
PMID:21505051
NCBI chr15:120,219,657...120,230,203
G
CYP19A3
cytochrome P450 19A3
multiple interactions
EXP
[epostane co-treated with Dinoprost] results in increased expression of CYP19A1 mRNA
CTD
PMID:20739670
NCBI chr 1:120,476,890...120,556,103
Ensembl chr 1:120,367,667...120,695,899
G
GHRL
ghrelin and obestatin prepropeptide
increases secretion multiple interactions
EXP
GHRL protein results in increased secretion of Dinoprost STAT1 protein inhibits the reaction [GHRL protein results in increased secretion of Dinoprost]
CTD
PMID:19528263
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
G
NFKBIA
NFKB inhibitor alpha
increases phosphorylation
EXP
Dinoprost results in increased phosphorylation of NFKBIA protein
CTD
PMID:21505051
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
G
OXT
oxytocin/neurophysin I prepropeptide
multiple interactions increases secretion increases abundance
EXP
Progesterone inhibits the reaction [OXT protein results in increased abundance of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprost]
CTD
PMID:16997130 PMID:21370738
NCBI chr17:32,605,586...32,606,449
Ensembl chr17:32,605,586...32,606,546
G
PLA2G1B
phospholipase A2 group IB
multiple interactions
EXP
[epostane co-treated with Dinoprost] results in increased expression of PLA2G1B mRNA
CTD
PMID:20739670
NCBI chr14:40,314,520...40,322,315
Ensembl chr14:40,314,520...40,322,315
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[epostane co-treated with Dinoprost] results in increased expression of PTGS2 mRNA
CTD
PMID:20739670
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
STAT1
signal transducer and activator of transcription 1
multiple interactions increases secretion
EXP
STAT1 protein inhibits the reaction [GHRL protein results in increased secretion of Dinoprost] STAT1 protein results in increased secretion of Dinoprost
CTD
PMID:19528263
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all